CFDP1 is required for histone variant H2A.Z deposition by the human SRCAP chromatin remodeling complex
Nucleic Acids Research · 24.10.2026 · 54 (20)
DOI: 10.1093/nar/gkag1099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 04.11.2026. Verfasst von Naoe Moro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, United States. Hauptthemen laut MEDLINE: Histones, Chromatin Assembly and Disassembly. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, American Heart Association.
Abstract (Originalsprache)
Craniofacial Developmental Protein 1 (CFDP1) is a member of the evolutionarily conserved family of Bucentaur (BCNT) proteins and is required for cell survival and differentiation during tooth development. Its yeast homolog is involved in histone variant H2A.Z deposition by the yeast SWR1C remodeler. Direct connections between CFDP1, H2A.Z deposition, and the mammalian SWR1 homolog, Snf2-Related CREBBP Activator Protein (SRCAP), are poorly understood. Here, we perform detailed biochemical reconstitution and characterization of the human SRCAP complex (SRCAP-C). We find that CFDP1 weakly interacts with SRCAP-C in a salt concentration-dependent manner and is essential for H2A.Z dimer exchange by SRCAP-C. We show that CFDP1 stimulates the basal ATPase activity of reconstituted SRCAP-C, suggesting a requirement for CFDP1 in regulating intrinsic catalytic ATPase activity. Additionally, CFDP1 deficiency in human induced pluripotent stem cells (hiPSCs) leads to a genome-wide reduction of H2A.Z, H3K27me3, and H3K4me3 deposition, accompanied by the upregulation of developmental genes normally marked by these modifications. Taken together, our results provide mechanistic insights into how CFDP1 regulates histone variant H2A.Z deposition by SRCAP-C. Given mutations in the SRCAP gene cause Floating-Harbor syndrome, a rare, dominant developmental disorder, our study provides an additional link between craniofacial development and SRCAP-mediated H2A.Z deposition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, United States.
- Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
ORCID-Profile: Craig L Peterson, Shinya Watanabe
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- American Heart Association
- NICHD NIH HHS
- NHLBI NIH HHS
- NIH
Zitieren
APA
Moro, N., Yang, D., Butty, V. L., Levine, S. S., Peterson, C. L., Boyer, L. A., & Watanabe, S. (2026). CFDP1 is required for histone variant H2A.Z deposition by the human SRCAP chromatin remodeling complex. Nucleic Acids Research, 54(20). https://doi.org/10.1093/nar/gkag1099
Vancouver
Moro N, Yang D, Butty VL, Levine SS, Peterson CL, Boyer LA, et al. CFDP1 is required for histone variant H2A.Z deposition by the human SRCAP chromatin remodeling complex. Nucleic Acids Research. 2026;54(20). doi:10.1093/nar/gkag1099
BibTeX
@article{Moro2026,
author = {Moro, Naoe and Yang, Dandan and Butty, Vincent L and Levine, Stuart S and Peterson, Craig L and Boyer, Laurie A and Watanabe, Shinya},
title = {CFDP1 is required for histone variant H2A.Z deposition by the human SRCAP chromatin remodeling complex},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {20},
doi = {10.1093/nar/gkag1099}
}
EUVIMED